PHARVARIS N V's ticker is PHVS and the CUSIP is N69605108. A total of 23 filers reported holding PHARVARIS N V in Q1 2022. The put-call ratio across all filers is - and the average weighting 1.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,044 | -94.7% | 50 | -96.2% | 0.00% | – |
| Q2 2023 | $19,682 | +479.1% | 1,300 | +208.1% | 0.00% | – |
| Q1 2023 | $3,399 | -89.2% | 422 | -84.9% | 0.00% | – |
| Q4 2022 | $31,500 | +75.0% | 2,800 | +250.4% | 0.00% | – |
| Q2 2022 | $18,000 | +38.5% | 799 | +9.8% | 0.00% | – |
| Q1 2022 | $13,000 | +116.7% | 728 | +72.1% | 0.00% | – |
| Q4 2021 | $6,000 | -50.0% | 423 | -35.3% | 0.00% | – |
| Q3 2021 | $12,000 | +1100.0% | 654 | +1943.8% | 0.00% | – |
| Q1 2021 | $1,000 | – | 32 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Foresite Capital Management IV, LLC | 3,743,450 | $78,125,802 | 43.39% |
| venBio Partners LLC | 4,264,672 | $89,003,705 | 25.24% |
| Bain Capital Life Sciences Investors, LLC | 4,784,674 | $99,856,146 | 11.17% |
| 5AM Venture Management, LLC | 587,600 | $12,263,212 | 3.53% |
| VR Adviser, LLC | 1,563,513 | $32,630,516 | 3.44% |
| Novo Holdings A/S | 1,329,325 | $27,743,013 | 2.05% |
| Cormorant Asset Management, LP | 1,361,460 | $28,413,670 | 1.66% |
| GENERAL ATLANTIC, L.P. | 4,406,252 | $91,958,479 | 1.42% |
| Foresite Capital Management V, LLC | 33,142 | $691,674 | 1.10% |
| Soleus Capital Management, L.P. | 343,975 | $7,178,758 | 0.66% |